Howard Weintraub, MD

  • Specialties: Cardiology, Preventive Cardiology
  • Language: English
  • Phone: 212-263-0855

About Me

Conditions and Treatments

atherosclerosis, high cholesterol level, lipid disorders, lipid metabolism, high blood pressure disorder, prediabetes, metabolic syndrome, coronary heart disease, type 2 diabetes mellitus, chest pain, fainting, arteriosclerosis, obesity, heart throbbing, aortic valve disease, congestive heart failure (CHF), heart murmur, heart valve diseases, abnormal heart rhythms, mitral valve prolapse (MVP), rapid heartbeat, slow heartbeat, rheumatic heart disease, pulmonary hypertension, mitral valve stenosis, arteriosclerosis, atrioventricular septal defect, atrial fibrillation, endothelial dysfunction, mitral valve disease, ventricular fibrillation, dilated cardiomyopathy, ventricular septal defect (VSD), carotid artery disease, arterial occlusive disease, chronic venous insufficiency, myocardial disease, myocarditis, heart attack, aortic valve insufficiency, ventricular arrhythmia, inflammation of the heart valve, renal artery stenosis, carotid stenosis, an inflammation of the membrane surrounding the heart, heart disease, peripheral vascular disease (PVD), vascular disease occlusive, atrial septal defect (ASD), aortic valve stenosis, cerebrovascular disorder, ischemic cardiomyopathy, renovascular, claudication, heart muscle disease, sarcoidosis, mitral regurgitation (MR), peripheral vascular disease (PVD), acute coronary syndrome, cardiac disease in pregnancy, angina, heart failure, heart tumor, ventricular tachycardia (V-tach)
Show More Conditions

Credentials

Positions
  • Clinical Professor, Department of Medicine
Board Certifications
  • American Board of Internal Medicine (Cardiovascular Disease), 1985
  • American Board of Internal Medicine - Internal Medicine, 1979
Education and Training
  • Fellowship, NYU Medical Center, Cardiology, 1982
  • Fellowship, NYU Medical Center, Pulmonary Diseases, 1980
  • Residency, NYU Medical Center, Medicine, 1979
  • MD from New York University, 1976
Departments

Locations and Appointments

41 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Cigna EPO/POS
  • Cigna PPO
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • HealthPlus Child Health (Amerigroup)
  • HealthPlus Family Health (Amerigroup)
  • HealthPlus Medicaid (Amerigroup)
  • HealthSmart (WTC)
  • Humana Medicare
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MultiPlan/PHCS PPO
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • WellCare Child Health
  • WellCare Family Health
  • WellCare Medicaid
  • WellCare Medicare
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYULMC Center for the Prevention of Cardiovascular Disease

530 1st Avenue, HCC, Suite 4F
New York, NY 10016

Contact

Phone: 212-263-0855

Schedule Online

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

We are involved in an exciting trial of a new class of medication to lower her LDL cholesterol. The patients who are being studied are those who had an acute coronary syndrome within the last year. this study we'll be looking at the effect of significant lowering of LDL cholesterol on cardiovascular events.

We are also involved in a study of omega-3 fatty acids in the reduction of cardiovascular events.

We are also investigating the cardiac effects of a new drug to treat type II diabetes.

The Center for Prevention of Cardiovascular Disease is also involved in a large trial that examines the effectiveness of different prevention modalities in patients with known coronary artery disease.

Publications

  • Prevalence of unrecognized diabetes, prediabetes and metabolic syndrome in patients undergoing elective percutaneous coronary intervention

    Balakrishnan, Revathi; Berger, Jeffrey S; Tully, Lisa; Vani, Anish; Shah, Binita; Burdowski, Joseph; Fisher, Edward; Schwartzbard, Arthur; Sedlis, Steven; Weintraub, Howard; Underberg, James A; Danoff, Ann; Slater, James A; Gianos, Eugenia
    Diabetes/metabolism research & reviews. 2015 Feb. 611-612

  • Reply to Letters Regarding Article, "Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III)" [Letter]

    Doran, Bethany; Guo, Yu; Xu, Jinfeng; Weintraub, Howard; Mora, Samia; Maron, David J; Bangalore, Sripal
    Circulation. 2015 May. 131 (19): ?-? e473

  • The role of testosterone therapy in cardiovascular mortality: culprit or innocent bystander?

    Tanna, Monique S; Schwartzbard, Arthur; Berger, Jeffery S; Alukal, Joseph; Weintraub, Howard
    Current atherosclerosis reports. 2015 Mar. 17 (3): 490-490

Read All Publications (41)